Pillstats
Rx only · Suspension/ Drops · Ophthalmic

Loteprednol Etabonate

Brands: Alrex · Eysuvis · Lotemax · Loteprednol Etabonate

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers10 labelers
Packages41
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 23 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$17.79$35.58$53.36$71.15Jan 2025Feb 2026Jun 2026
$27.870
Latest avg · Jun 17, 2026
-55%
Since Jan 1, 2025
8
Active US suppliers
34%
Top-2 supplier share*

Who makes it8 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch & Lomb Incorporatedunknown7SUPPLYING
Armas Pharmaceuticals Inc.unknown5SUPPLYING
Padagis US LLCunknown5SUPPLYING
Sentiss Pharmaceuticals LLCunknown5SUPPLYING
Amneal Pharmaceuticals LLCunknown5SUPPLYING
Bausch & Lomb Americas Inc.unknown4SUPPLYING
Alcon Laboratories, Inc.unknown3SUPPLYING
Sportpharm LLCunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3EXITED 2026
NorthStar RxLLCunknown3EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.